Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-13

Clinical Trial Update: A Study to Assess utiLity of BIoEP as an Early Prognostic Indicator for Predicting Anti-Seizure Medication (ASM) Efficacy

View source ↗

Summary

A clinical trial update describing a study to assess BioEP as an early prognostic indicator for predicting antiseizure medication efficacy in epilepsy, which is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Neuronostics Ltd | Conditions: Epilepsy | Status: NOT_YET_RECRUITING